Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants

Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants

Tommy Tsang Cheung,1,* Tu H Mai,2,* Yen Lin Chia,2 Desmond YH Yap,1 Chi-Ho Lee,1 Cecil Chi-Keung Chen,2 Ying Huang,3 Yuwen Jin,3 James Johnston,4 Viktoria Werkström,5 Yuhui Yao,6 Xiaoyun Ge,7 Wenying Zheng8 1Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Ho...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Cheung TT, Mai TH, Chia YL, Yap DYH, Lee CH, Chen CC, Huang Y, Jin Y, Johnston J, Werkström V, Yao Y, Ge X, Zheng W
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Dove Medical Press 2023-01-01
Sarja:Drug Design, Development and Therapy
Aiheet:
benralizumab
pharmacokinetics
healthy chinese
Linkit:https://www.dovepress.com/safety-tolerability-and-pharmacokinetics-of-benralizumab-a-phase-1-ran-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/safety-tolerability-and-pharmacokinetics-of-benralizumab-a-phase-1-ran-peer-reviewed-fulltext-article-DDDT

Samankaltaisia teoksia